Page last updated: 2024-08-24

xanomeline and choline

xanomeline has been researched along with choline in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bymaster, FP; Calligaro, DO; Mitch, CH; Olesen, PH; Sauerberg, P; Schoepp, DD; Shannon, HE; Sheardown, MJ; Suzdak, PD; Swedberg, MD; Ward, JS; Wong, DT	1
Bodick, N; Offen, WW; Renshaw, PF; Satlin, A	1
Abou-Gharbia, M; Bartolomeo, AC; Boast, CA; Buccafusco, JJ; Husbands, MG; Kille, N; Morris, H; Moyer, JA; Rosenzweig-Lipson, S; Sabb, AL	1

Trials

1 trial(s) available for xanomeline and choline

Article	Year
Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist. The American journal of psychiatry, 1997, Volume: 154, Issue:10 Topics: Acetylcholine; Alzheimer Disease; Brain; Choline; Creatine; Dose-Response Relationship, Drug; Drug Administration Schedule; Frontal Lobe; Glycerylphosphorylcholine; Humans; Magnetic Resonance Spectroscopy; Muscarinic Antagonists; Neurons; Parasympathetic Nervous System; Protons; Pyridines; Thiadiazoles	1997

Article

Year

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.

The American journal of psychiatry, 1997, Volume: 154, Issue:10

Topics: Acetylcholine; Alzheimer Disease; Brain; Choline; Creatine; Dose-Response Relationship, Drug; Drug Administration Schedule; Frontal Lobe; Glycerylphosphorylcholine; Humans; Magnetic Resonance Spectroscopy; Muscarinic Antagonists; Neurons; Parasympathetic Nervous System; Protons; Pyridines; Thiadiazoles

1997

Other Studies

2 other study(ies) available for xanomeline and choline

Article	Year
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232). The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Acetylcholinesterase; Administration, Oral; Animals; Biological Availability; Brain; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Male; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Parasympathomimetics; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Salivation; Thiadiazoles	1994
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2 Topics: Animals; Aziridines; Behavior, Animal; Brain; Bridged-Ring Compounds; Choline; Choline O-Acetyltransferase; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Female; Frontal Lobe; Hippocampus; Hypothermia; Macaca mulatta; Male; Mice; Muscarinic Agonists; Neuromuscular Blocking Agents; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Salivation; Scopolamine; Thiadiazoles; Time Factors; Visual Cortex	2000

Article

Year

Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).

The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Acetylcholinesterase; Administration, Oral; Animals; Biological Availability; Brain; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Male; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Parasympathomimetics; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Salivation; Thiadiazoles

1994

The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.

The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

Topics: Animals; Aziridines; Behavior, Animal; Brain; Bridged-Ring Compounds; Choline; Choline O-Acetyltransferase; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Female; Frontal Lobe; Hippocampus; Hypothermia; Macaca mulatta; Male; Mice; Muscarinic Agonists; Neuromuscular Blocking Agents; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Salivation; Scopolamine; Thiadiazoles; Time Factors; Visual Cortex

2000